Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial

PMID: 280535082014

0gene entries

13mutation entries

AMR Mutations

Gene	Protein Change	Nucleotide Change	Mechanism	Organism	Resistance To	Database	Validation Status
rplC	G155R	-	-	Methicillin-resistant Staphylococcus, Staphylococcus aureus, Methicillin-sensitive Staphylococcus	Tedizolid\|Linezolid	Reslit	-
rplD	K68Q	-	-	Staphylococcus aureus, Enterococcus faecium, Staphylococcus epidermidis, Methicillin-resistant Staphylococcus	Tedizolid\|Linezolid	Reslit	-
rplC	G152D	-	-	Staphylococcus aureus, Methicillin-resistant Staphylococcus, Methicillin-sensitive Staphylococcus	Tedizolid\|Linezolid	Reslit	-